Covid drug and vac­cine sales nose­dive, dent­ing bio­phar­ma rev­enue across the board

Mod­er­na re­port­ed a steep de­cline in Covid-19 vac­cine sales in the first quar­ter that mim­ic­ked a plunge in rev­enue re­port­ed by oth­er man­u­fac­tur­ers of Covid …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER